Presentation Information

[4P-0206 (4AT1-18-08)]The prostaglandin J2 metabolic pathway acts as an endogenous checkpoint for necroptosis through direct RIPK1 inhibition

○Yusuke Imagawa1,2, Yoshihide Tsujimoto3 (1.Osaka Intl. Cancer Inst., Res. Ctr., Dept. Oncog. Growth Regul., 2.Grad. Sch. of Pharm. Sci., Univ. of Osaka, 3.Osaka Intl. Cancer Inst., Res. Ctr.)

Password required to view

Password required to view or download.
Check your name badge for the password.

Comment

To browse or post comments, you must log in.Log in